http://rdf.ncbi.nlm.nih.gov/pubchem/reference/427704

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 10
issn 1687-9112
1687-9104
pageRange 683065-10
publicationName Advances in Hematology
startingPage 683065
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8e6d331b6d5d0246c1359633e77f71c7
bibliographicCitation Dutour A, Marin V, Pizzitola I, Valsesia-Wittmann S, Lee D, Yvon E, Finney H, Lawson A, Brenner M, Biondi A, Biagi E, Rousseau R. In VitroandIn VivoAntitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL againstCD33+Acute Myeloid Leukemia. Advances in Hematology. 2012;2012():1–10. doi: 10.1155/2012/683065.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe7578e29ee2761d54b0dab8d16f8c1d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85c377d5dd3c64cfa49219d0e608fd76
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3101fac8211e0f9ead8f42cee36603c3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56dc9919d0055b46d8cdb1729339baa1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b2915b3edca39106996be61ed36310c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f04e52e4e165ca1effa27ee2a97632a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_519894fd8fa8b181bfcbb72143a1a247
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8b0f9a1a7fb83c38e00d1101b70d271
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6ee14cad4b99a0ca1266a450541a30b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a56e977befc7988fe9b714254b954073
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94e307f2189763c88d888e399e20e2f5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ba20a496d6c06e14e36a4668f1bfe6c
date 2012
identifier https://pubmed.ncbi.nlm.nih.gov/22272203
https://pubmed.ncbi.nlm.nih.gov/PMC3261457
https://doi.org/10.1155/2012/683065
isPartOf https://portal.issn.org/resource/ISSN/1687-9104
https://portal.issn.org/resource/ISSN/1687-9112
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35826
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title In VitroandIn VivoAntitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL againstCD33+Acute Myeloid Leukemia
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449435
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7cae9972de6deccb83ee4f720cac0e7d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1d2c6279569a5e5473d9efe0530fd802

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136137642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128756287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127866646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888769

Total number of triples: 43.